8 Spam-Free Article(s) Found
Sort:
Date
Filter:
7d
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
T AT&T Inc. $33.62 $244.15B N/A
Article Searches
2 Great Income Stocks to Buy Right Now https://www.fool.com/investing/2020/09/27/2-great-income-stocks-to-buy-right-now/?source=iedfolrf0000001 Sep 27, 2020 - These stocks pay big dividends and should help your portfolio stand up to market turbulence.
The Zacks Analyst Blog Highlights: AT&T, Philip Morris, Square, Zoom and Vale http://www.zacks.com/stock/news/1063183/the-zacks-analyst-blog-highlights-att-philip-morris-square-zoom-and-vale?cid=CS-ZC-FT-press_releases-1063183 Sep 24, 2020 - The Zacks Analyst Blog Highlights: AT&T, Philip Morris, Square, Zoom and Vale
Top Analyst Reports for AT&T, Philip Morris & Square http://www.zacks.com/research-daily/1062298/top-analyst-reports-for-att-philip-morris-square?cid=CS-ZC-FT-research_daily-1062298 Sep 23, 2020 - Top Analyst Reports for AT&T, Philip Morris & Square
AT&T & Microsoft Extend Tie-Up for Secure IoT Cloud Services http://www.zacks.com/stock/news/1062216/att-microsoft-extend-tie-up-for-secure-iot-cloud-services?cid=CS-ZC-FT-analyst_blog|company_news_tech_sector-1062216 Sep 23, 2020 - AT&T's (T) partnership with Microsoft is likely to sow the seeds of technology convergence of secure cloud computing and intricate network management skills to help businesses unlock customer value.
bluebird-Bristol Myers' CAR T Cell Therapy BLA Accepted by FDA http://www.zacks.com/stock/news/1062352/bluebird-bristol-myers-car-t-cell-therapy-bla-accepted-by-fda?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-1062352 Sep 23, 2020 - The FDA accepts bluebird (BLUE) and Bristol Myers Squibb's BLA for idecabtagene vicleucel for the treatment of adult patients with multiple myeloma.
FDA Accepts Application for Bristol-Myers Squibb and bluebird bio's Multiple Myeloma CAR-T Therapy https://www.fool.com/investing/2020/09/22/fda-accepts-application-for-bristol-myers-squibb-a/?source=iedfolrf0000001 Sep 22, 2020 - The Food and Drug Administration's acceptance means it will issue a go/no-go decision on ide-cel in March 2021.
Looking for a Growth Stock? 3 Reasons Why T. Rowe (TROW) is a Solid Choice http://www.zacks.com/stock/news/1061835/looking-for-a-growth-stock-3-reasons-why-t-rowe-trow-is-a-solid-choice?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_11_growth-1061835 Sep 22, 2020 - T. Rowe (TROW) possesses solid growth attributes, which could help it handily outperform the market.
Will Netflix's (NFLX) Cuties Debacle Aid New Streaming Peers? http://www.zacks.com/stock/news/1061704/will-netflixs-nflx-cuties-debacle-aid-new-streaming-peers?cid=CS-ZC-FT-analyst_blog|industry_focus-1061704 Sep 22, 2020 - Rise in Netflix's (NFLX) subscription cancellations over Cuties is likely to create opportunity for new streaming challengers including Disney+, Peacock and HBO Max among others.

Pages: 1

Page 1